Credit Suisse’s Tiziana Life Sciences TLSA Stock Holding History

Credit Suisse’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,960	Closed	-$1.79K	–	3696
2022 Q4	$1.79K	Hold	2,960	–	–	﹤0.01%	3552
2022 Q3	$2K	Sell	2,960 -2,500	-46%	-$1.88K	﹤0.01%	3767
2022 Q2	$4K	Sell	5,460 -5,128	-48%	-$4.41K	﹤0.01%	3766
2022 Q1	$11K	Buy	+10,588	New	+$9.38K	﹤0.01%	3544
2021 Q1	–	Sell	-20,000	Closed	-$40K	–	4556
2020 Q4	$40K	Buy	+20,000	New	+$63.2K	﹤0.01%	4268

Other funds holding TLSA

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AFP

Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return

Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Credit Suisse's TLSA Position: Q1 2023 in Review

Credit Suisse sold out of Tiziana Life Sciences (TLSA) in Q1 2023, closing a stake of 2,960 shares — an estimated $1.79K sold.

Credit Suisse first reported a position in TLSA in Q4 2020 and held it in 5 quarters. The position peaked at $40K in Q4 2020. 18 funds tracked by Wall St. Rank hold TLSA as of Q1 2023.

Credit Suisse reported no remaining Tiziana Life Sciences position as of Q1 2023 after selling out during the quarter.
Credit Suisse sold 2,960 Tiziana Life Sciences shares in Q1 2023, an estimated $1.79K.
Credit Suisse first reported a position in Tiziana Life Sciences in Q4 2020 and held it in 5 quarters.
Credit Suisse's Tiziana Life Sciences position peaked at $40K in Q4 2020.
18 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.